• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗前储存生殖材料的癌症幸存者的生殖经历和结局调查。

Survey of Reproductive Experiences and Outcomes of Cancer Survivors Who Stored Reproductive Material Before Treatment.

机构信息

Jean Hailes Research Unit, School of Public Health and Preventive Medicine, Monash University, Victoria, Australia.

Victorian Assisted Reproductive Treatment Authority, Victoria, Australia.

出版信息

Hum Reprod. 2017 Dec 1;32(12):2423-2430. doi: 10.1093/humrep/dex314.

DOI:10.1093/humrep/dex314
PMID:29045667
Abstract

STUDY QUESTION

What are the reproductive experiences and outcomes of people who store reproductive material before cancer treatment?

SUMMARY ANSWER

Of respondents who had tried to achieve pregnancy since completing cancer treatment almost all had succeeded, in most cases through natural conception.

WHAT IS KNOWN ALREADY

People of reproductive age who are diagnosed with cancer can cryopreserve reproductive material to guard against the adverse effects on fertility of gonadotoxic treatment. Little is known about the reproductive outcomes of people who undergo fertility preservation before cancer treatment.

STUDY DESIGN, SIZE, DURATION: Cross-sectional survey.

PARTICIPANTS/MATERIALS, SETTING, METHODS: Women and men who had stored reproductive material before cancer treatment at two private and one public fertility clinics up to June 2014 and were at least 18 years old at the time were identified from medical records and invited to complete an anonymous questionnaire about their reproductive experiences.

MAIN RESULTS AND THE ROLE OF CHANCE

Of the 870 potential respondents 302 (171 female and 131 male) returned completed questionnaires yielding a response rate of 34.5% (39.5% and 29.7% for female and male respondents, respectively). Current age was similar for women and men (37.2 years) but men had been diagnosed with cancer significantly earlier in life than women (28.2 versus 30.3 years, P = 0.03). Almost two-thirds of respondents wished to have a child or another child in the future, some of whom knew that they were unable to. One in ten respondents was a parent before the cancer diagnosis and around one-third had had a child since diagnosis or was pregnant (or a partner in pregnancy) at the time of the survey. Of those who had tried to conceive since completing cancer treatment (N = 119) 84% (79% of women and 90% of men) had had a child or were pregnant (or a partner in pregnancy). Most of the pregnancies since the diagnosis of cancer occurred after natural conception (58/100, 58%). Of the 22 women (13% of all women) and 35 men (27% of all men) who had used their stored reproductive material four women (18%) and 28 men (80%) had had a child or were pregnant or a partner in pregnancy at the time of completing the survey. The most commonly stated reason for not using the stored material was not being ready to try for a baby.

LIMITATIONS, REASON FOR CAUTION: The relatively low response rate, particularly among men, means that participation bias may have influenced the findings. As type of cancer was self-reported and we did not ask questions about respondents' cancer treatments, it is not possible to link reproductive outcomes to type of cancer or cancer treatment. Also, there is no way of comparing the sample with the populations they were drawn from as data on reproductive outcomes of people who store reproductive material before cancer treatment are not collected routinely. This might have led to over- or underestimates of the reproductive experiences and outcomes reported in this paper.

WIDER IMPLICATIONS OF THE FINDINGS

The findings add to the limited evidence about the reproductive outcomes of this growing group of people and can be used to inform the advice given to those contemplating fertility preservation in the context of cancer.

STUDY FUNDING/COMPETING INTERESTS: The study was funded by the National Health and Medical Research Council (APP1042347). The authors have no conflicts of interest to declare.

TRIAL REGISTRATION NUMBER

Not applicable.

摘要

研究问题

在接受癌症治疗之前储存生殖材料的人有哪些生殖经历和结果?

总结答案

在完成癌症治疗后尝试怀孕的受访者中,几乎所有人都成功了,大多数情况下是通过自然受孕。

已知信息

被诊断患有癌症的育龄人士可以冷冻保存生殖材料,以防止性腺毒性治疗对生育能力产生不利影响。对于在癌症治疗前进行生育保存的人的生殖结果知之甚少。

研究设计、大小、持续时间:横断面调查。

参与者/材料、地点、方法:从两家私人和一家公共生育诊所的病历中确定了截至 2014 年 6 月之前接受过癌症治疗前储存生殖材料且年龄至少 18 岁的女性和男性,并邀请他们填写一份关于其生殖经历的匿名问卷。

主要结果和机会的作用

在 870 名潜在受访者中,有 302 名(女性 171 名,男性 131 名)人返回了完整的问卷,回复率为 34.5%(女性和男性的回复率分别为 39.5%和 29.7%)。女性和男性的当前年龄相似(37.2 岁),但男性被诊断出癌症的年龄明显小于女性(28.2 岁对 30.3 岁,P = 0.03)。近三分之二的受访者希望未来有一个孩子或另一个孩子,其中一些人知道自己无法生育。十分之一的受访者在癌症诊断前已经是父母,大约三分之一的人在诊断后已经有了孩子或怀孕(或怀孕的伴侣)。在完成癌症治疗后尝试怀孕的受访者中(N = 119),84%(女性 79%,男性 90%)已经有了孩子或怀孕(或怀孕的伴侣)。自癌症诊断以来的大多数怀孕都是自然受孕(58/100,58%)。在使用储存的生殖材料的 22 名女性(所有女性的 13%)和 35 名男性(所有男性的 27%)中,有 4 名女性(18%)和 28 名男性(80%)已经有了孩子或怀孕或怀孕的伴侣。未使用储存材料的最常见原因是还没准备好要孩子。

局限性、谨慎的原因:相对较低的回复率,尤其是在男性中,意味着参与偏见可能影响了研究结果。由于癌症类型是自我报告的,我们没有询问受访者的癌症治疗问题,因此无法将生殖结果与癌症类型或癌症治疗联系起来。此外,由于没有办法将样本与他们所来自的人群进行比较,因为没有收集到癌症治疗前储存生殖材料的人的生殖结果数据,因此报告的生殖经历和结果可能存在高估或低估的情况。

研究结果的更广泛意义

这些发现增加了关于这一不断增长的人群生殖结果的有限证据,可以为那些在癌症背景下考虑生育保存的人提供建议。

研究资金/利益冲突:该研究由澳大利亚国家健康与医学研究委员会(APP1042347)资助。作者没有利益冲突需要申报。

临床试验注册号

不适用。

相似文献

1
Survey of Reproductive Experiences and Outcomes of Cancer Survivors Who Stored Reproductive Material Before Treatment.治疗前储存生殖材料的癌症幸存者的生殖经历和结局调查。
Hum Reprod. 2017 Dec 1;32(12):2423-2430. doi: 10.1093/humrep/dex314.
2
Reproductive experiences of women who cryopreserved oocytes for non-medical reasons.因非医学原因冷冻卵子的女性的生殖经历。
Hum Reprod. 2017 Mar 1;32(3):575-581. doi: 10.1093/humrep/dew342.
3
Reproductive choices and outcomes after freezing oocytes for medical reasons: a follow-up study.出于医学原因冷冻卵母细胞后的生殖选择与结局:一项随访研究
Hum Reprod. 2014 Sep;29(9):1925-30. doi: 10.1093/humrep/deu137. Epub 2014 Jun 20.
4
Experiences and intentions of patients undergoing medically indicated oocyte or embryo cryopreservation: a qualitative study.医学指征下的卵母细胞或胚胎冷冻保存患者的体验和意愿:一项定性研究。
Hum Reprod. 2024 Jan 5;39(1):147-153. doi: 10.1093/humrep/dead228.
5
Beyond fertility preservation: role of the oncofertility unit in the reproductive and gynecological follow-up of young cancer patients.超越生育力保存:oncofertility 单位在年轻癌症患者生殖和妇科随访中的作用。
Hum Reprod. 2019 Aug 1;34(8):1462-1469. doi: 10.1093/humrep/dez108.
6
Psychosocial experiences of involuntary definitive childless women: a comparative study based on reproductive status.非自愿性永久性不孕女性的心理社会体验:基于生殖状态的比较研究。
Hum Reprod. 2024 Mar 1;39(3):559-568. doi: 10.1093/humrep/deae001.
7
Infertility and pregnancy outcomes among adults with primary ciliary dyskinesia.原发性纤毛运动障碍成年患者的不孕不育与妊娠结局
Hum Reprod Open. 2024 Jun 18;2024(3):hoae039. doi: 10.1093/hropen/hoae039. eCollection 2024.
8
Monitoring fertility (semen analysis) by cancer survivors who banked sperm prior to cancer treatment.对癌症治疗前储存精子的癌症幸存者进行生育力(精液分析)监测。
Hum Reprod. 2012 Nov;27(11):3132-9. doi: 10.1093/humrep/des300. Epub 2012 Aug 27.
9
Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.将生育力保存程序结合起来,将卵子分散到不同的篮子里:一项可行性研究。
Hum Reprod. 2020 Nov 1;35(11):2524-2536. doi: 10.1093/humrep/deaa193.
10
Long-term follow-up to assess criteria for ovarian tissue cryopreservation for fertility preservation in young women and girls with cancer.对癌症年轻女性和女孩的卵巢组织冷冻保存以保留生育能力的标准进行长期随访评估。
Hum Reprod. 2023 Jun 1;38(6):1076-1085. doi: 10.1093/humrep/dead060.

引用本文的文献

1
Are we Only Doing Good? Long-term Psychosocial Effects of Fertility Preservation (or Lack Thereof) on Survivors of Cancer During Adolescence and Young Adulthood.我们只是在做好事吗?生育力保存(或未进行生育力保存)对青少年和青年期癌症幸存者的长期心理社会影响。
Cancer J. 2025;31(4). doi: 10.1097/PPO.0000000000000774. Epub 2025 Aug 11.
2
Fertility preservation through oocyte or embryo vitrification prior to oncological treatment: a 12-year experience.肿瘤治疗前通过卵母细胞或胚胎玻璃化冷冻进行生育力保存:12年经验
J Assist Reprod Genet. 2025 May;42(5):1453-1459. doi: 10.1007/s10815-025-03522-5. Epub 2025 May 30.
3
Outcomes of female fertility preservation with cryopreservation of oocytes or embryos in the Netherlands: a population-based study.
荷兰卵母细胞或胚胎冷冻保存的女性生育力保存结局:一项基于人群的研究。
Hum Reprod. 2024 Dec 1;39(12):2693-2701. doi: 10.1093/humrep/deae243.
4
Fertility preservation in female cancer patients in Brazil: perceptions and attitudes of infertility specialists.巴西癌症女性患者的生育力保存:不孕不育专家的认知和态度。
Rev Bras Ginecol Obstet. 2024 Apr 9;46. doi: 10.61622/rbgo/2024rbgo25. eCollection 2024.
5
Survey of Long-Term Experiences of Sperm Cryopreservation in Oncological and Non-Oncological Patients: Usage and Reproductive Outcomes of a Large Monocentric Cohort.肿瘤患者和非肿瘤患者精子冷冻保存的长期经验调查:一个大型单中心队列的使用情况和生殖结局
Front Oncol. 2021 Nov 5;11:772809. doi: 10.3389/fonc.2021.772809. eCollection 2021.
6
Chemotherapy-based gonadotoxicity risk evaluation as a predictor of reproductive outcomes in post-pubertal patients following ovarian tissue cryopreservation.基于化疗的性腺毒性风险评估作为青春期后患者卵巢组织冷冻保存后生殖结局的预测指标。
BMC Womens Health. 2021 May 13;21(1):201. doi: 10.1186/s12905-021-01343-z.
7
Counseling young women with early breast cancer on fertility preservation.对早期乳腺癌的年轻女性进行生育力保存咨询。
J Assist Reprod Genet. 2019 Dec;36(12):2593-2604. doi: 10.1007/s10815-019-01615-6. Epub 2019 Nov 23.
8
Rising Incidence of Breast Cancer in the Young Fertile Indian Population-a Reality Check.印度年轻育龄人群中乳腺癌发病率上升——现实审视
Indian J Surg Oncol. 2018 Sep;9(3):296-299. doi: 10.1007/s13193-018-0800-4. Epub 2018 Jul 23.